Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31411213 | 1.00 | ALDH1A1 (0.73) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL7943115 | 0.89 | ALDH1A1 (0.59) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL31315462 | 0.88 | ALDH1A1 (0.64) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL29358687 | 0.84 | ALDH1A1 (1.00) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL50705 | 0.84 | ALDH1A1 (1.00) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL30382738 | 0.83 | ALDH1A1 (0.57) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL13454410 | 0.83 | ALDH1A1 (0.57) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL5681640 | 0.82 | ALDH1A1 (0.52) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL18826219 | 0.82 | ALDH1A1 (0.52) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL12078076 | 0.82 | ALDH1A1 (0.95) | ALDH1A1ALOX15HPGDHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106349024-A | Synthesis method and application of hindered phenol antioxidant | 彤程化学（中国）有限公司 | 2017-01-25 | — | — | CN | disclosed |
| EP-2271651-B1 | ISOTHERMAL PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-01-01 | — | — | EP | disclosed |
| EP-2346887-B1 | SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2013-12-25 | — | — | EP | disclosed |
| US-8546600-B2 | Slurry process for synthesis of bisphosphites and situ use thereof for producing bisphosphite | DOW TECHNOLOGY INVESTMENTS LLC | 2013-10-01 | — | — | US | disclosed |
| EP-2257560-B1 | SLURRY PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | UNION CARBIDE CHEM PLASTIC (US) | 2013-07-17 | — | — | EP | disclosed |
| US-8471066-B2 | Slurry process for phosphoromonochloridite synthesis | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2013-06-25 | — | — | US | disclosed |
| US-8097749-B2 | Isothermal process for phosphoromonochloridite synthesis | Union Carbide Chemical and Plastics Technology Technology | 2012-01-17 | — | — | US | disclosed |
| US-20110196166-A1 | SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE | DOW TECHNOLOGY INVESTMENTS LLC | 2011-08-11 | — | — | US | disclosed |
| US-20110021840-A1 | SLURRY PROCESS FOR PHOSPHOROMONOCHLORIDITE SYTHESIS | UNION CARBIDE CORPORATION | 2011-01-27 | — | — | US | disclosed |
| EP-2271651-A1 | ISOTHERMAL PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | Dow Global Technologies Inc. (US) | 2011-01-12 | — | — | EP | disclosed |
| EP-2257560-A1 | SLURRY PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | Union Carbide Chemicals & Plastics Technology Llc (Formerly Union Carbide Chemicals & Plastics Technology Corporation) (US) | 2010-12-08 | — | — | EP | disclosed |
| WO-2009120210-A1 | ISOTHERMAL PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-10-01 | — | — | WO | disclosed |
| US-20090247790-A1 | ISOTHERMAL PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | UNION CARBIDE CORPORATION | 2009-10-01 | — | — | US | disclosed |
| WO-2009120529-A1 | SLURRY PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC (FORMERLY UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION) (US) | 2009-10-01 | — | — | WO | disclosed |
| EP-0590613-B1 | Improved hydroformylation process | UNION CARBIDE CHEM PLASTIC (US) | 1997-01-08 | — | — | EP | disclosed |
| EP-0590613-A2 | Improved hydroformylation process | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1994-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247790-A1 | ISOTHERMAL PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | PIM3, PLCB3, PLCD1 | ALDH1A1 4149/4885ALOX15 2223/4885HPGD 3289/4885 |
| US-20110196166-A1 | SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE | SOST, PLCB3, PPIP5K2 | ALDH1A1 4653/4885ALOX15 2202/4885HPGD 3513/4885 |
| US-20110021840-A1 | SLURRY PROCESS FOR PHOSPHOROMONOCHLORIDITE SYTHESIS | PSPH, SPIN3, SYNGR2 | ALDH1A1 4865/4885ALOX15 3604/4885HPGD 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.